ESC Premium Access

When to start and when to stop beta-blockers in acute coronary syndromes and (nearly) normal ventricular function

Congress Presentation

About the speaker

Professor Etienne Puymirat

European Hospital Georges Pompidou, Paris (France)
2 presentations
0 follower

3 more presentations in this session

When to start and when to stop P2Y12 inhibitors in acute coronary syndromes

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Thumbnail

When to start and when to stop ACE-I/ARB in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Doctor B. Gersh (Rochester, US)

Thumbnail

Early administration of lipid lowering agents in acute coronary syndromes.

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

Access the full session

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Speakers: Professor E. Puymirat, Doctor D. Angiolillo, Doctor B. Gersh, Professor C. Cannon
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

Mode of intervention in mitral regurgitation.

28 August 2021

ESC Premium Access

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

28 August 2021

ESC Premium Access

Transcatheter treatment for degenerative mitral regurgitation

27 August 2021

ESC 365 is supported by

logo Novo Nordisk